ARO-DIMER-PA

N/A

Report date: 2025/10/20 11:31:38
NME

Base Information

Drug NameARO-DIMER-PA
Drug Alias NameARO-DIMER-PA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitorsApolipoprotein C-III inhibitorsRNA interference
TargetsProprotein convertase subtilisin kexin type 9Apolipoprotein C-III
Therapy Area/IndicationsHyperlipidemiasHyperlipidemia, Familial Combined
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHyperlipidemia, Familial Combined
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A